Sivasakthi Medical Systems India Private Limited
ANCHOR Trial
DESCRIPTION
Device
Angiolite
Number of patients
103
Follow up
24 month
Type of lesions
De-novo lesions
OUTCOMES
Primary endpoints
Strut coverage at 3 months
Secondary endpoints
0.07%
In-stent Late Lumen Loss
0%
24 month
Type of lesions
De-novo lesions
CONCLUSIONS
“These low rates are demonstrating an excellent stent performance”
In ANCHOR, Angiolite demonstrated a favorable early healing profile assessed with OCT at 3 and 6-month post PCI.
This was characterized by high rates of strut coverage and very low rates of in-stent LLL.
Imaging data were also coupled with favorable 24-month clinical data characterized by the absence of binary in-stent restenosis, stent thrombosis, myocardial infarction or cardiac death, suggesting a highly efficacy of Angiolite.